Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Plos Pathogens|April 10, 2018
HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodiesSimone I Richardson, Amy W Chung, Harini Natarajan, et al.
Plos Pathogens|December 17, 2019
IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibodySimone I Richardson, Bronwen E Lambson, Andrew R Crowley, et al.
Scientific Reports|June 10, 2024
Evaluating the antibody response elicited by diverse HIV envelope immunogens in the African green monkey (Vervet) modelThandeka Moyo-Gwete, Frances Ayres, Nonkululeko B Mzindle, et al.
Iscience|July 31, 2025
SARS-CoV-2 vaccines elicit differential Fc effector functionsNelia P Manamela, Boitumelo M Motsoeneng, Holly Spencer, et al.
Plos Pathogens|February 25, 2020
Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodiesThach H Chu, Andrew R Crowley, Iara Backes, et al.
Scientific Reports|January 21, 2023
Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineagesJinal N Bhiman, Simone I Richardson, Bronwen E Lambson, et al.
Journal of Virology|December 12, 2023
Development of LIBRA-seq for the guinea pig model system as a tool for the evaluation of antibody responses to multivalent HIV-1 vaccinesMatthew J Vukovich, Nagarajan Raju, Prudence Kgagudi, et al.
Frontiers in Immunology|August 21, 2023
Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccinationBoitumelo M Motsoeneng, Nelia P Manamela, Haajira Kaldine, et al.
Retrovirology|June 25, 2015
South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4β7 for replicationSimone I Richardson, Elin S Gray, Nonhlanhla N Mkhize, et al.
Pageof 5